Skip to content

Transanal minimally invasive surgery via robot for rectal benign and stage IA malignant tumors: a prospective observational study

Transanal minimally invasive surgery via robot for rectal benign and stage IA malignant tumors: a prospective observational study

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100051075
Enrollment
Unknown
Registered
2021-09-11
Start date
2021-09-01
Completion date
Unknown
Last updated
2022-05-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

rectal cancer

Interventions

Test group:Robot-assisted local full-thickness rectal resection

Sponsors

Department of General Surgery, the First Medical Center, Chinese PLA General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Aged >= 18 years; 2. Those who are weak, have major diseases, are older, or have a strong desire to preserve their anus; 3. Colonoscopy: the lower edge of the tumor is less than or equal to 15cm from the anal verge, the pathology shows rectal adenocarcinoma, high-grade intraepithelial neoplasia, rectal polyps or adenomas (giant, sessile, recurrent, suspicious cancerous or unresectable under endoscopy), rectal carcinoid (<= 20 mm); 4. Rectal endoscopic ultrasonography, pelvic enhanced CT, rectal enhanced MRI: the lower edge of the tumor is <=15cm from the anal verge, the stage is T1 or below (initial assessment <= cT1N0M0 or reassessment after neoadjuvant therapy <=ycT1N0M0), no lymph node metastasis, no distant metastasis; 5. Concomitant diseases without absolute contraindications to surgery.

Exclusion criteria

Exclusion criteria: 1. Patients with a history of pelvic radiotherapy; 2. Patients with peritoneal implantation; 3. Refuse to participate in the researcher.

Design outcomes

Primary

MeasureTime frame
3-year disease-free survival rate;3-year overall survival;

Secondary

MeasureTime frame
3-year local recurrence rate;Sexual function one year after surgery;Urination function 1 year after operation;Quality of life of cancer patients;

Countries

China

Contacts

Public ContactZhang Chaojun

Department of General Surgery, the First Medical Center, Chinese PLA General Hospital

zcjdlyxzx@163.com+86 18600317036

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026